Well, we've now had our Olympia Snowe moment. But watch out, she's got her finger on the trigger.
Now, we move on to the Harry Reid, Chuck Schumer, get the most liberal plan possible moment.
Then the Nancy Pelosi moment.
Then the reconciliation moment.
Then the filibuster moment, maybe an Al Franken moment.
Then, a law, including the public option, I think maybe -- watered down somehow.
I think the public option will ride in on the strength of the CBO numbers. This isn't an easy sell, but it can be made: the public option is cheaper, because it offers choice
The battle lines are drawn. A spokesman for the insurance industry's trade group said Monday: "We cannot support this legislation in its current structure." To which the White House responded, "The insurance industry has decided to lead the charge against health reform, and everyone recognizes their motives: profits."
The likely trillion dollar price tag on this prospective legislation should be measured against total health care costs for the country of about three trillion dollars. Health care costs have risen faster than inflation and the growth in national income.
Many of these costs could be sharply reduced without any reference to the current Washington debate about insurance.
Take misdiagnosis: error rates of 1.4% in cancer biopsies; 20-40% in emergency room and ICU care. Patient surveys of misdiagnosis range from 8% to 40%.
The two top underlying preventable causes of death are tobacco and obesity. Relatively recent statistics -- the year 2000 -- listed the causes of death accordingly: tobacco (435,000; 18.1%), poor diet and physical inactivity (400,000;16.6%), alcohol consumption (85,000;3.5%),. Other causes: microbial agents (75,000), toxic agents (55,000), motor vehicle crashes (43,000), incidents involving firearms (29,000), sexual behaviors (20,000), drug abuse (17,000).
Just off the top of my head, that's about 2.5 million preventable deaths. Add that to misdiagnosis. I can't tell you that number. It is certainly big. And both tobacco and obesity threaten more people than just the sufferers.
The US rates 38th in the world in life expectancy; 21st among developed countries. Canada's life expectancy average is 82.1 years. The life expectancy for citizens of France is 80.9 years and the everage life expectancy of those living in the U.K. is 78.9 years. In the United States, the average life expectancy is 78.1. But more important than life expectancy averages is the fact that in each of of those nations, every single citizen has access to health care. The United States is the only developed country in the world that does not offer health care to all of its citizens.
Though people born in other countries live longer than in the U.S., Americans who make it to 55 years of age live 8-9 months longer, because of an excellent level of surgery, end-of-life treatment, advanced testing and expensive prescription drugs. And these are precisely the items in which most money is invested.
A high percentage of medical treatment is devoted to iatrogenic, i.e., doctor caused, illness.
It is estimated that the number of people having in-hospital, adverse drug reactions to prescribed medicine is 2.2. million,
The CDC has estimated that "tens of millions" of antibiotics are prescribed unnecessarily for viral infections every year.
The number of unnecessary medical and surgical procedures performed annually is 7.5 million, about 30%.
The number of people exposed to unnecessary hopspitalization annually is 8.9 million.
For these reasons, some experts say the medical system itself is a greater cause of death than either heart disease or cancer.
Cancer recently passed heart disease as the leading cost of death in the U.S. And as baby boomers age, cancer numbers will continue to grow dramatically, even if current economic conditions do not improve. The total cost per year is already about $210 billion.
Great progress has been made in both heart and cancer treatment. But some of the advances are chimerical. Stents, for example, are given to many heart patients who don't need them, who are not even manifesting the requisite symptoms.
To treat an aggressive cancer with drugs like herceptin, avastin and zometa can cost up to $300,000 per patient per year.
In a USA article in July, an expert is cited: "These therapies may give patients a few more months, but they are not a cure. Given those limitations (he) and others question whether these drugs are worth it." In fact, as new drugs are developed, they tend to have a narrower efficacy, and therefore a higher price. (Those of you who've been following the health care debate, will be thinking "death panels" at this point) .
In 1965, approx. 5% of US GDP was spent on health care. In 2004, heaalth expenditures were approx. 16% of GDP, and it is projected that by 2014 we will be spending nearly 20% of GDP on health care. Examining the numbers more carefully shows that we are not, however, overly efficient in spending money to cover these costs nor to keep them in some kind of check. In fact it is not surprising that the CBO says the Baucus/Snowe plan and, for that matter, the public option, will save money by allowing consumer choice.
Choice of what? How about starting with the things that both matter most and are free, or close to free: diet, environment, activity, psychology (high self-esteem). Each of us can start working on those four areas tomorrow. No insurance required, private or public.
My favorite example is bottled water. 89 billion liters are consumed worldwide every year, worth roughly $22 million. Half is drunk in Western Europe, where it was already part of the culture before the current explosion, because of pollution of the water supply for centuries.
There are studies showing bottled mineral water to contain harmful substances, including arsenic.
Americans drink 240 to 10,000 times as much bottled water as tap water, even though in many cases the tap water is healthier, and in some cases like Dasani and Aquafina, the bottled water IS tap water.
The global bottled water industry has exploded to over $35 billion. That does not buy health. It would buy a public option.